Bayer Aktienges Ads (BAYRY)
$15.54 0.35 (2.20%)
13:11 EDT BAYRY Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 54.19B
PE Ratio -
Volume (Avg. Vol.) 173,945
Day's Range 15.41 - 15.60
52-Week Range 12.55 - 21.59
Dividend & Yield 0.60 (3.89%)
BAYRY Stock Predictions, Articles, and Bayer Aktienges Ads News
- From InvestorPlace
- From the Web
Bayer stock is down more than 8% Wednesday as a jury deemed the company's Roundup weedkiller responsible for causing cancer. Here's why.
With several domestic and geopolitical factors likely to swing the markets unpredictably, defensive stocks remain your best bet.
These 3 dividend stocks have both growth and income on tap, and are among Warren Buffett's picks that other investors should consider.
Here are the five stocks hedge fund guru Warren Buffett boosted in the last quarter according to just-released SEC filings. Also included is analysis from the Street's top analysts so investors can decide whether to add these latest Warren Buffett stock picks to their own portfolio.
With the U.S. Fed deciding to turn off the quantitative easing tap, one of the smartest plays would be to go for mega-cap stocks, which still have high growth p...
Despite the uncertainty in the healthcare business, drug stocks have been doing well. Check out these three large cap pharma stocks today
JD.com, China's No. 2 e-commerce operator, delivered a first-quarter earnings report that has JD stock popping on Monday.
Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat
On Oct 7, 2016, we issued an updated research report on premium agro-chemical firm Monsanto. Here's how we view MON stock's prospects today
Bayer stock doesn't get much love thanks to its over-the-counter (OTC) listing, but BAYRY is a buy if this buyout goes through.
The Monsanto (MON) buyout finally comes to fruition, Herbalife (HLF) is up on Icahn's latest ramblings and Exelixis (EXEL) gets a big green light in Europe.
3 Stocks to Watch Tuesday: Monsanto Company (MON), Biogen Inc (BIIB) and Navistar International Corp (NAV)
Bayer (BAYRY) ups its bid for Monsanto (MON), Navistar (NAV) rockets higher on Volkswagen (VLKAY) interest and Biogen (BIIB) absorbs a downgrade.
A deal between Monsanto (MON) and Bayer (BAYRY) was rejected, but it's not dead yet, and would be one more notch in the consolidation of the food industry.
Monsanto (MON) stock holders may want to take the money and run while the Bayer offer is still on the table.
Markets are mixed heading into the afternoon even as a power play is ongoing at the board of National Amusements, majority shareholders at Viacom and CBS
Monsanto stock was up after it confirmed on Thursday that Bayer is currently in early talks with it over an acquisition deal.
Mergers and acquisitions are back at levels not seen since before the financial crisis, led by these giant deals.
From Seeking Alpha
AVEO Oncology (NASDAQ:AVEO) announces that final results from the Phase 3 TIVO-3 study comparing Fotivda (tivozanib) to Bayer's (OTCPK:BAYRY) Nexavar (sorafenib) in renal cell carcinoma (RCC) patients in third- and fourth-line settings were just published in the journal European Urology.Consistent with its announcement in May, the trial met the primary endpoint demonstrating tivozanib's superiority in extending progression-free survival (PFS) with 27% less risk of cancer progression.
From Seeking Alpha
From Jakubowitz Law
NEW YORK, NY / ACCESSWIRE / September 14, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't
DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bayer Aktiengesellschaft and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm